Humility Versus Humiliation: The Fine Line of Student Discomfort Reply

被引：0

作者：

Brown, Amy E. Caruso ^{[1
]}

机构：

[1] SUNY Upstate Med Univ, Bioeth & Humanities & Pediat, Syracuse, NY 13210 USA

来源：

ACADEMIC MEDICINE | 2020年 / 95卷 / 05期

关键词：

D O I：

暂无

中图分类号：

G40 [教育学];

学科分类号：

040101 ; 120403 ;

摘要：

引用

页码：669 / 669

页数：1

共 34 条

[31] Reply to comment on "Anastrozole (Arimidex ™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women:: survival analysis and updated safety results" by H.T.!Mouridsen, H.A.!Chaudri-Ross
Nabholtz, JM
EUROPEAN JOURNAL OF CANCER, 2004, 40 (07) : 1097 - 1097
[32] Reply to FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS-mutated tumours in the randomised German AIO study KRK-0306
Pietrantonio, F.
Garassino, M. C.
Torri, V.
de Braud, F.
ANNALS OF ONCOLOGY, 2012, 23 (10) : 2771 - 2772
[33] Reply to Alessia Cimadamore, Liang Cheng, Marina Scarpelli, et al's Letter to the Editor re: Alfonso Gomez de Liano Lista, Nick van Dijk, Guillermo de Velasco Oria de Rueda, et al. Clinical Outcome After Progressing to Frontline and Second-line Anti-PD-1/PD-L1 in Advanced Urothelial Cancer. Eur Urol 2020;77:269-76. Progression and Hyperprogression Versus Pseudoprogression: Morphologic Documentation
van Dijk, Nick
de Liano Lista, Alfonso Gomez
Szabados, Bernadett
Powles, Thomas
van der Heijden, Michiel S.
EUROPEAN UROLOGY, 2021, 79 (01) : E20 - E21
[34] Reply to Pontus Eriksson, Gottfrid Sjodahl, and Fredrik Liedberg's Letter to the Editor re: Thomas Powles, Robert A. Huddart, Tony Elliott, et al. Phase III, Double-blind, Randomized Trial that Compared Maintenance Lapatinib versus Placebo after First-line Chemotherapy in Patients with Human Epidermal Growth Factor Receptor 1/2-positive Metastatic Bladder Cancer. J Clin Oncol 2017;35:48-55. Knowing HER2 Status is Not Enough: A Molecular Subtype Approach to Bladder Cancer is Also Needed Protein Expression to Predict Outcome to Targeted Therapy in Bladder Cancer: Too Little, Too Late?
Powles, Thomas
de Liano, Alfonso Gomez
Ackerman, Charlotte
EUROPEAN UROLOGY, 2017, 72 (05) : E137 - E138

← 1 2 3 4 →